AdvisorNet Financial Inc Acquires 510 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

AdvisorNet Financial Inc raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 66.0% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,283 shares of the medical equipment provider's stock after purchasing an additional 510 shares during the quarter. AdvisorNet Financial Inc's holdings in Intuitive Surgical were worth $635,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ISRG. Brighton Jones LLC grew its position in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after buying an additional 731 shares during the period. Union Bancaire Privee UBP SA purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $6,509,000. Caprock Group LLC grew its position in shares of Intuitive Surgical by 9.5% in the 4th quarter. Caprock Group LLC now owns 9,041 shares of the medical equipment provider's stock worth $4,719,000 after buying an additional 788 shares during the period. Austin Private Wealth LLC boosted its stake in Intuitive Surgical by 1,117.2% in the 4th quarter. Austin Private Wealth LLC now owns 779 shares of the medical equipment provider's stock worth $407,000 after purchasing an additional 715 shares in the last quarter. Finally, Clear Creek Financial Management LLC boosted its stake in Intuitive Surgical by 2.0% in the 4th quarter. Clear Creek Financial Management LLC now owns 1,582 shares of the medical equipment provider's stock worth $826,000 after purchasing an additional 31 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Up 0.0%

Intuitive Surgical stock traded up $0.11 during midday trading on Thursday, hitting $558.06. The stock had a trading volume of 1,241,906 shares, compared to its average volume of 1,644,331. The firm's fifty day moving average is $520.78 and its two-hundred day moving average is $539.13. The company has a market capitalization of $200.02 billion, a PE ratio of 87.06, a P/E/G ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a 52-week low of $405.08 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period in the prior year, the firm posted $1.50 EPS. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on ISRG. Truist Financial dropped their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Piper Sandler dropped their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Barclays dropped their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday. Finally, Citigroup reiterated a "buy" rating and issued a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus target price of $596.05.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the sale, the executive vice president now directly owns 5,224 shares of the company's stock, valued at $2,695,113.84. This trade represents a 3.47% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Mark Brosius sold 215 shares of the firm's stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $552.07, for a total transaction of $118,695.05. Following the completion of the transaction, the senior vice president now directly owns 1,338 shares of the company's stock, valued at approximately $738,669.66. This trade represents a 13.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 25,716 shares of company stock valued at $12,831,288 in the last three months. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.